DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
SALVIANOLIC ACID A
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus; Diabetic Neuropathies
Unknown
SALVIANOLIC ACID A
×
Maximum Phase:
1
First Approval:
None
UNII:
51622542XO
Molecule Type:
Small molecule
Molecular Formula:
C26H22O10
Molecular Weight:
494.45
AlogP:
3.34
PSA:
184.98
HBD:
7.0
HBA:
#RotB:
8.0
Source:
NAPHTHALENE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
NAPHTHALENE
×
Maximum Phase:
1
First Approval:
None
UNII:
2166IN72UN
Molecule Type:
Small molecule
Molecular Formula:
C10H8
Molecular Weight:
128.17
AlogP:
2.84
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
FF-10101
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 inhibitor
FF-10101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H38N8O2
Molecular Weight:
530.68
AlogP:
3.13
PSA:
126.28
HBD:
3.0
HBA:
#RotB:
13.0
Source:
EM-1421
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EM-1421
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RAVUCONAZOLE
1
Small molecule
Investigational
Unknown
Unknown
Mycoses
Cytochrome P450 51 inhibitor
RAVUCONAZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
95YH599JWV
Molecule Type:
Small molecule
Molecular Formula:
C22H17F2N5OS
Molecular Weight:
437.48
AlogP:
4.24
PSA:
87.62
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOSIFLOXURIDINE NAFALBENAMIDE
1
Small molecule
Investigational
Unknown
Unknown
Colorectal Neoplasms; Neoplasms
Unknown
FOSIFLOXURIDINE NAFALBENAMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
4YO6QT3SZ9
Molecule Type:
Small molecule
Molecular Formula:
C29H29FN3O9P
Molecular Weight:
613.54
AlogP:
3.4
PSA:
158.18
HBD:
3.0
HBA:
#RotB:
11.0
Source:
AZD-8330
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
AZD-8330
×
Maximum Phase:
1
First Approval:
None
UNII:
G4990BOZ66
Molecule Type:
Small molecule
Molecular Formula:
C16H17FIN3O4
Molecular Weight:
461.23
AlogP:
1.83
PSA:
92.59
HBD:
3.0
HBA:
#RotB:
6.0
Source:
MILCICLIB MALEATE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
MILCICLIB MALEATE
×
Maximum Phase:
1
First Approval:
None
UNII:
82W826FL6S
Molecule Type:
Small molecule
Molecular Formula:
C29H36N8O5
Molecular Weight:
576.66
AlogP:
2.57
PSA:
91.21
HBD:
2.0
HBA:
#RotB:
4.0
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
TALETRECTINIB ADIPATE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TALETRECTINIB ADIPATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H34FN5O5
Molecular Weight:
551.62
AlogP:
4.43
PSA:
77.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
DS-7423
1
Small molecule
Investigational
Unknown
Unknown
Colorectal Neoplasms; Endometrial Neoplasms
PI3-kinase class I inhibitor
DS-7423
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TCD-717
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Choline kinase alpha inhibitor
TCD-717
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FISOGATINIB
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
FISOGATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
5Q7R99CKV2
Molecule Type:
Small molecule
Molecular Formula:
C24H24Cl2N4O4
Molecular Weight:
503.39
AlogP:
4.49
PSA:
94.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
RXDX-105
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RXDX-105
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZELOPRAZOLE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux
Unknown
AZELOPRAZOLE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
KDJ60607ON
Molecule Type:
Small molecule
Molecular Formula:
C22H26N3NaO4S
Molecular Weight:
451.52
AlogP:
3.66
PSA:
86.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
FK453
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor antagonist
FK453
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H25N3O2
Molecular Weight:
375.47
AlogP:
3.78
PSA:
57.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
XANOMELINE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Muscarinic acetylcholine receptor M1 agonist
XANOMELINE
×
Maximum Phase:
1
First Approval:
None
UNII:
9ORI6L73CJ
Molecule Type:
Small molecule
Molecular Formula:
C14H23N3OS
Molecular Weight:
281.43
AlogP:
3.22
PSA:
38.25
HBD:
0.0
HBA:
#RotB:
7.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
PLX-7486
1
Small molecule
Investigational
Unknown
Unknown
Giant Cell Tumors
Macrophage colony stimulating factor receptor inhibitor
PLX-7486
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZELOPRAZOLE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZELOPRAZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
MIR2G6L61B
Molecule Type:
Small molecule
Molecular Formula:
C22H27N3O4S
Molecular Weight:
429.54
AlogP:
3.66
PSA:
86.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
FLUOROACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLUOROACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
AP1JV9U41M
Molecule Type:
Small molecule
Molecular Formula:
C2H3FO2
Molecular Weight:
78.04
AlogP:
0.04
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
MSX-122
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
C-X-C chemokine receptor type 4 antagonist
MSX-122
×
Maximum Phase:
1
First Approval:
None
UNII:
69D634Q702
Molecule Type:
Small molecule
Molecular Formula:
C16H16N6
Molecular Weight:
292.35
AlogP:
2.49
PSA:
75.62
HBD:
2.0
HBA:
#RotB:
6.0
Source:
CT-1578
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Macrophage colony stimulating factor receptor inhibitor
CT-1578
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK3207
1
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders
Calcitonin gene-related peptide type 1 receptor antagonist
MK3207
×
Maximum Phase:
1
First Approval:
None
UNII:
5C44M1QYCC
Molecule Type:
Small molecule
Molecular Formula:
C31H29F2N5O3
Molecular Weight:
557.6
AlogP:
3.77
PSA:
103.43
HBD:
3.0
HBA:
#RotB:
4.0
Source:
DIINDOLYLMETHANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIINDOLYLMETHANE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TELENZEPINE
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
TELENZEPINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0990EG3K10
Molecule Type:
Small molecule
Molecular Formula:
C19H22N4O2S
Molecular Weight:
370.48
AlogP:
2.53
PSA:
55.89
HBD:
1.0
HBA:
#RotB:
2.0
Source:
VT-1598
1
Small molecule
Investigational
Unknown
Unknown
Coccidioidomycosis
Unknown
VT-1598
×
Maximum Phase:
1
First Approval:
None
UNII:
AV9K9X720D
Molecule Type:
Small molecule
Molecular Formula:
C31H20F4N6O2
Molecular Weight:
584.53
AlogP:
4.88
PSA:
109.74
HBD:
1.0
HBA:
#RotB:
8.0
Source:
BMS-214662
1
Small molecule
Investigational
Unknown
Unknown
Anemia, Refractory, with Excess of Blasts; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
BMS-214662
×
Maximum Phase:
1
First Approval:
None
UNII:
L2U9GFD244
Molecule Type:
Small molecule
Molecular Formula:
C25H23N5O2S2
Molecular Weight:
489.63
AlogP:
4.17
PSA:
93.09
HBD:
1.0
HBA:
#RotB:
6.0
Source:
.ALPHA.-PYRROLIDINONONANOPHENONE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
.ALPHA.-PYRROLIDINONONANOPHENONE
×
Maximum Phase:
1
First Approval:
None
UNII:
S3FKL8RY1D
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO
Molecular Weight:
287.45
AlogP:
4.69
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
9.0
Source:
RG7185
1
Small molecule
Investigational
Unknown
Unknown
Unknown
G protein-coupled receptor 44 antagonist
RG7185
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RO-4987655
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
RO-4987655
×
Maximum Phase:
1
First Approval:
None
UNII:
I3733P75ML
Molecule Type:
Small molecule
Molecular Formula:
C20H19F3IN3O5
Molecular Weight:
565.29
AlogP:
3.16
PSA:
100.13
HBD:
3.0
HBA:
#RotB:
8.0
Source:
1
2
…
75
76
77
78
79
80
81
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA